92 related articles for article (PubMed ID: 30165034)
1. A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials.
Ogasawara A; Matsushita H; Tanaka Y; Shirasugi Y; Ando K; Asai S; Miyachi H
Clin Chim Acta; 2019 Feb; 489():249-253. PubMed ID: 30165034
[TBL] [Abstract][Full Text] [Related]
2. Predicting chronic leukaemias from assessment of complete peripheral blood counts.
Hayran M; Koca E; Haznedaroglu IC; Unsal I; Durgun B; Guvenc F; Ozturk B; Ratip S; Ozcebe OI
J Int Med Res; 2006; 34(6):640-7. PubMed ID: 17294996
[TBL] [Abstract][Full Text] [Related]
3. Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia.
Gaspar BL; Sharma P; Varma N; Sukhachev D; Bihana I; Naseem S; Malhotra P; Varma S
Biomed J; 2019 Apr; 42(2):93-98. PubMed ID: 31130253
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic significance of the differential blood count in patients with chronic myeloid leukemia].
Zankovich R; Schilling H; Thiele J; Kvasnicka HM; Diehl V
Med Klin (Munich); 1989 Aug; 84(8):373-7. PubMed ID: 2796866
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
[TBL] [Abstract][Full Text] [Related]
6. Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?
Kelani R; Monem F
Int J Lab Hematol; 2015 Oct; 37(5):723-8. PubMed ID: 26059167
[TBL] [Abstract][Full Text] [Related]
7. Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.
Agis H; Krauth MT; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz LB; Printz D; Böhm A; Fritsch G; Horny HP; Valent P
J Clin Pathol; 2006 Apr; 59(4):396-402. PubMed ID: 16461568
[TBL] [Abstract][Full Text] [Related]
8. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
[TBL] [Abstract][Full Text] [Related]
9. Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia.
Chikkodi SV; Malhotra P; Naseem S; Khadwal A; Prakash G; Sahu KK; Kumari S; Suri V; Varma N; Varma S
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S114-9. PubMed ID: 26297263
[TBL] [Abstract][Full Text] [Related]
10. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia.
Jönsson S; Olsson B; Jacobsson S; Palmqvist L; Ricksten A; Ekeland-Sjöberg K; Wadenvik H
Scand J Clin Lab Invest; 2011 Feb; 71(1):7-11. PubMed ID: 20863169
[TBL] [Abstract][Full Text] [Related]
12. The relationship between interleukin-3-like activity and basophil production in chronic myeloid leukemia patients.
Fishman P; Sredni B; Djaldetti M
Immunol Lett; 1991 Apr; 28(1):73-7. PubMed ID: 2071173
[TBL] [Abstract][Full Text] [Related]
13. [Isolated thrombocytosis in chronic myeloid leukemia without significant leukocytosis].
Okano M; Sugimoto Y; Ohishi K; Miyazaki K; Monma F; Katayama N
Rinsho Ketsueki; 2017; 58(7):766-771. PubMed ID: 28781272
[TBL] [Abstract][Full Text] [Related]
14. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
16. [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].
Jonte F; Barez A; Soto I; Rayón C; Carrera D; Coma A; Pérez Llanderal J; Arribas M
Sangre (Barc); 1992 Oct; 37(5):345-50. PubMed ID: 1293773
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum granulocyte colony-stimulating factor in patients with chronic myeloid leukemia.
Saitoh H; Shibata A
Leuk Lymphoma; 1993 Nov; 11(5-6):443-6. PubMed ID: 7510191
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features?
Cervantes F; Colomer D; Vives-Corrons JL; Rozman C; Montserrat E
Leukemia; 1996 Jul; 10(7):1241-3. PubMed ID: 8684009
[TBL] [Abstract][Full Text] [Related]
19. [Expression of SALL4 gene in patients with acute and chronic myeloid leukemia].
Chen Q; Qian J; Lin J; Yang J; Li Y; Wang CZ; Chai HY; Chen XX; Qian Z; Ma JC; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):315-9. PubMed ID: 23628023
[TBL] [Abstract][Full Text] [Related]
20. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
